Shanghai Zhao'An Medical Technology

Shanghai Zhao'An Medical Technology is a specialized medical device company focused on the research, development, and commercialization of neuro-interventional solutions. Founded in 2015 and acquired by Peijia Medical in 2021, the company provides a comprehensive portfolio of products for the treatment of cerebrovascular diseases, including ischemic and hemorrhagic strokes. Its flagship offerings include the Z-Course intracranial self-expanding stent and the Z-Power stent retriever, which are designed to improve clinical outcomes in neurovascular procedures. Zhao'An Medical leverages advanced engineering in stent braiding and catheter extrusion to compete in the high-growth Chinese neuro-intervention market. As a key subsidiary of Peijia Medical, it plays a vital role in the parent company's strategy to offer a full suite of minimally invasive neurovascular treatments.